Polylactide matrix

Fig. 1.9 (A) Exfoliation of clay platelets (white Cloisite25A and Cloisite30B after (B) two and a arrows) in a commercial polylactide matrix using half months hydrolysis and (C) after five and a a masterbatch process. (B, C) Visual aspect half months hydrolysis. (A) adapted from [144] of unfilled PLA, microcomposite based on reproduced by permission ofWiley-VCH, and CloisiteNa+, and nanocomposites based on (B, C) from [147] with permission from Elsevier.

The use of biodegradable polymers, especially polylactic acid (PLA), in oral solid dosage forms has been reported in the literature. PLA has been used as a matrix for phenobarbital tablets (9). Similarly, the use of polylactide as a matrix for oral dosage form of naproxen has also been reported (10). 

One of the potential applications of these ABC triblock copolymers was explored by Hillmyer and coworkers in 2005 [118]. They have prepared nanoporous membranes of polystyrene with controlled pore wall functionality from the selective degradation of ordered ABC triblock copolymers. By using a combination of controlled ring-opening and free-radical polymerizations, a triblock copolymer polylactide-/j-poly(A,/V-dimethylacrylamide)-ib-polystyrene (PLA-h-PDMA-h-PS) has been prepared. Following the self-assembly in bulk, cylinders of PLA are dispersed into a matrix of PS and the central PDMA block localized at the PS-PLA interface. After a selective etching of the PLA cylinders, a nanoporous PS monolith is formed with pore walls coated with hydrophilic PDMA. 

Polymeric micropsheres, particularly those prepared from the biodegradable polylactide/ polyglycolide polymers, have been widely investigated as a means to achieve sustained parenteral drug delivery. The advantage of formulating the polymeric matrix as microspheres is the ability to administer them via a conventional needle and syringe as a suspension formulation, rather than as an implant (see below). Lupron depot formulations are available which can provide therapeutic blood levels of leuprolide acetate for up to four months. These products are presented as lyophilized polylactic acid microspheres which are reconstituted to form a suspension prior to administration. 

The above mentioned scaffolds were made completely of the ceramic materials. Other potential materials which could be used to fabricate a novel construct for the repair of ciitical-sized bone defects is a novel material made of biodegradable polymer reinforced with ceramics particles. The properties of such a composite depend on 1) properties of the polymer used for the matrix and properties of the ceramics used for the reinforcement, 2) composition of the composite (i.e. content of ceramic particles) and 3) size, shape and arrangement of the particles in the matrix. Several polymer-composite composites have been used for scaffolds fabrication including polylactide (PLA) and polycaprolacton (PCL) reinforced with calcium phosphate (CaP) micro and nanoparticles. Authors proposed a novel composite material by blending copolymer -Poly(L-lactide-co-D,E-lactide) (PLDLLA) a copolymer with a ceramic - Tri-Calcium Phosphate... 

The second concept for the generation of monolithic polymers is based on diblock copolymers which were prepared by Hillmyer and coworkers [27]. These copolymers contain oriented nanoscopic cylinders of the degradable polymer polylactide (PLA) which were embedded in polystyrene. The latter served as an inert thermoplastic matrix, while PLA could be selectively removed under well-defined conditions using sodium hydroxide in aqueous methanol. The resulting mesoporous monolithic polystyrene contains nanochannels with defined pore size. The major drawback of this material free of any cross-linker is associated with reduced mechanical and chemical stability. 

Jeyanthi R, Thanoo BC, Metha RC, DeLuca PP. Effect of solvent removal techniqne on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. Journal of Controlled Release. 1996 38 235-244. 

Matrix detachable coils (Boston Scientific Neurovascular) are another example of modified endovascular coils, employing a stainless steel delivery wire coated with a bioabsorbable copolymer of 90% polyglycolide and 10% polylactide. In a study by Murayama et al. (2003), matrix detachable coils were shown to accelerate the rate of aneurysm healing in swine aneurysm models, specifically by promoting the formation of a thick neointimal layer at the aneurysm neck more quickly bare platinum coils (Murayama et al, 2003). Taschner et al. (2005) evaluated the use of Matrix detachable coils in 25 patients with intracranial aneurysms. Again, stable emboUzed aneurysms were achieved over a six-month period, but only when Matrix coils were used in conjunction with bare platinum coils (Taschner et al, 2005). 

Hakarainen, M., Karlsson, S. and Albertsson, A.C. (2000) Rapid (bio)degradation of polylactide by mixed culture of compost microorganisms-low molecular weight products and matrix changes. Polymer, 41,2331-2338. 

The conductive and biodegradable nano composite was made of PPy and polylactide [264,265]. PPy nanoparticles were incorporated into the poly-lactide matrix via the emulsion polymerization of pyrrole in the aqueous... 

---